Company / Corporate
ARCA.
Follow ARCAARCA biopharma is dedicated to developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development.[1]
01Deal
Deals on Carrywatch
Every deal that names ARCA, and its role in each.
Oruka Therapeutics, Inc. / ARCA
Oruka Therapeutics and ARCA biopharma merger proceeds under agreement
See deal detailsDeal Web
ARCA and 1 firm it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02Form 8-K Current Report
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming ARCA:
- P01